Event format
Language
English
We offer our registered users tailored information, free online courses and exclusive content.
English
EMOTION. Business & travel Ltd
Congress Manager: Alina Protsenko
T +38 044 257 5501 - F +38 (044) 257 0085 - office@emotion-bt.com
The registration includes:
• Scientific sessions
• Coffee breaks and lunch
• Educational materials
• Certificate of attendance
Dinner is not included
Controlled ovarian stimulation (COS) now plays a major role in optimising IVF outcomes by facilitating control of different aspects of the process and increasing the number of oocytes available. COS aims to achieve maximal success with minimal side effects. Progress in and understanding of ovarian physiology, as well as new advances in ovarian stimulation strategies have made it possible for healthcare professionals to achieve the optimal outcomes for patients.
Success in assisted reproductive technology (ART) depends on carefully controlled conditions in every step of the laboratory routine.
In addition, continuous advances in technology require constant revision of good laboratory practices and the introduction of new techniques. This educational activity will improve the participants’ knowledge of the latest technologies and laboratory practice guidelines.
The learning activity offers an interactive programme with specialised lectures tailored to fit the needs of physicians and embryologists working in ART, followed by lectures and case studies.Learners will have the opportunity to discuss, directly with renowned scientists, pertinent topics that have been the subject of controversy and innovation. Discussions will concentrate on how to facilitate optimal laboratory conditions, culture environments, selection criteria and how to select the best therapy for infertile patients.
By attending this live intervention, participants will be able to:
• Define laboratory and clinical outcomes for defining success in ART
• Key factors influencing the success of ART
• Tailor the best stimulation protocol for patients undergoing ART
• Discuss and debate changing approaches to ART
07:45 Registration
08.30 Opening
R. Fischer, Germany
08:40 Welcome Introduction - State of the ART in Baltic countries
A. Salumets, Estonia
Session I
Chair: Robert Fischer – Andres Salumets
09.00 L1 What is success in ART and the importance of oocyte numbers for cumulative
live-birth-rates
S. K. Sunkara, UK
09.25 Q&A
09.35 L2 How to define subgroups for COS?
C. Alviggi, Italy
10.00 Q&A
10.10 Panel discussion
10.45 Coffee break
Session II
Chair: Robert Fischer – Uliana Dorofeyeva
11.05 L3 What kind and dose of gonadotropins to use? Are biosimillars an option?
S. Kol, Israel
11.30 Q&A
11.40 L4 From poor response to low prognosis: The POSEIDON concept
R. Fischer, Germany
12.05 Q&A
12:15 L5 The management of The 4 Poseidon groups and the role of LH
C. Alviggi, Italy
12:40 Panel discussion
13:00 Lunch
14:00 L6 Triggering for ovulation- What are the options (hCG,GnrHa,Dual triggering)?
S. Kol, Israel
14.25 Q&A
14:35 L7 A quality management for COS-The “Fischer Concept”
R. Fischer, Germany
15:00 Q&A
15:10 Panel discussion
15:25 L8 The role of recent advancement in laboratory technology to improve ART outcome
(Time Lapse; Vitrification)
M. Meseguer, Spain
15:50 Q&A
16:00 L9 The role of pre-implantation testing for aneuploidy to improve selection.
What are the limits?
M. Meseguer, Spain
16:25 Q&A
16:35 Coffee break
Session III
Chair: Robert Fischer – Volodymyr Kotlik
17:00 L10 Endometrial receptivity testing for personalized infertility treatment
A. Salumets, Estonia
17:20 Q&A
17:30 L11 Is the time ready for “freeze-all” strategy for all patients?
What is the best frozen embryo transfer protocol?
S. K. Sunkara, UK
17.55 Q&A
18:05 Panel discussion
All Speakers
18:30 Concluding remarks
R. Fischer, Germany
End of the workshop
EXCEMED is a nonprofit foundation dedicated, since the last four decades, to the development of high-quality medical education programmes all over the world.
EXCEMED adheres to the guidelines and standards of the European Accreditation Council for Continuing Medical Education (EACCME ®) which states that continuing medical education must be balanced, independent, objective, and scientifically rigorous.
All EXCEMED programmes are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products. These views are the responsibility of the named speakers and do not represent an endorsement or recommendation on the part of EXCEMED.